Kegg medicus dgroup en
| DG00726 | |
| DG number | DG00726 |
| Classification | DGroup |
| Name | Irinotecan TYPE Chemical |
| Stem | - |
| Structural formula |  |
| Member | D08086 Irinotecan (INN) D01061 Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP18) D10642 Irinotecan sucrosofate (USAN) |
| Upper group | Antineoplastic DG01529 Topoisomerase inhibitor DG01526 Topoisomerase I inhibitor Metabolizing enzyme substrate DG01633 CYP3A/CYP3A4 substrate DG02913 CYP3A4 substrate DG02970 CES substrate DG02924 UGT substrate DG03183 UGT1A1 substrate |
| Remark | ATC code: L01CE02 |
| Comment | - |